Myeong-Ho Lee

Title: Myeong-Ho Lee: Innovator in Blood Glucose Monitoring Technology

Introduction

Myeong-Ho Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of devices for monitoring blood glucose levels. With a total of 2 patents, his work has the potential to improve the lives of individuals managing diabetes.

Latest Patents

Myeong-Ho Lee's latest patents include a personal blood glucose meter and an abnormal measurement detection method using the same. This innovative personal blood glucose meter features a sensor strip for collecting and applying a blood sample, which includes a reagent. The device comprises an electrode unit with multiple electrodes that receive the blood sample to generate electric current based on potential differences. An MCU measures the current values generated from the electrode unit to determine whether the glucose value of the blood sample is normal or abnormal. Additionally, a potential supply unit applies a predetermined potential to the electrode unit, while a display unit shows the resultant output from the MCU.

Another notable patent is the composition of redox-reagents for an electrochemical biosensor. This composition contains a metal-containing complex and thionine or its derivative as an electron transfer mediator for use in an electrochemical biosensor. The invention significantly increases glucose detection efficiency and is less affected by high humidity and interfering substances. This composition is particularly useful in fabricating electrochemical biosensors for detecting glucose in blood.

Career Highlights

Myeong-Ho Lee is currently employed at I-Sens, Inc., where he continues to innovate in the field of medical devices. His work has garnered attention for its practical applications in diabetes management.

Collaborations

Myeong-Ho Lee has collaborated with notable colleagues, including Geun Sig Cha and Tae Eun Kim, to advance his research and development efforts.

Conclusion

Myeong-Ho Lee's contributions to blood glucose monitoring technology exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving the quality of life for individuals with diabetes through advanced medical devices.